Our findings revealed that not only is SMAD5 up-regulated through BMPs treatment, but TGF-β1 can also induce SMAD5 in K562 CML cells (Figure 3A(Fig. 3)). This evidence concerns the gene CLN5 and chronic myelogenous leukemia, BCR-ABL1 positive.